Delcath Systems Inc

DCTH · NASDAQ · Healthcare / Medical Devices

20.55USD-0.83 (-3.88%)

Price History

Full chart

Market Stats

Previous Close21.38

Open21.44

Day Range20.21 – 21.44

52-Week Range8.12 – 17.42

Volume675.19K

Market Cap557.96M

P/E (TTM)1608.00

Forward P/E232.56

EPS0.01

Dividend Yield0.00%

Beta0.57

50-Day Avg15.23

200-Day Avg11.71

About

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Gerard J. Michel MBA, MS
Employees156
Headquarters566 Queensbury Avenue, Queensbury, NY, United States, 12804, USA
Websitehttps://www.delcath.com

Leadership

Mr. Gerard J. Michel MBA, MSCEO & Director · b. 1963
Dr. Martha S. Rook Ph.D.Chief Operating Officer · b. 1970
Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.Chief Medical Officer · b. 1967
Ms. Sandra Pennell C.P.A.Chief Financial Officer · b. 1979
Mr. David Hoffman J.D.General Counsel, Corporate Secretary & Chief Compliance Officer · b. 1970
Dr. Johnny John M.D.Senior Vice President of Clinical Operations & Medical Affairs · b. 1964
Mr. Kevin MuirChief Commercial Officer
Dr. Michael Brunner M.D.Senior Vice President of Interventional Oncology

Financials

Income Statement

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	346.00K	790.00K	1.07M	1.75M	1.99M	2.71M	3.41M	1.58M	1.65M	3.56M	2.72M	2.06M	37.20M	85.23M
Growth (%)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+128.32%	+35.32%	+63.42%	+14.02%	+36.30%	+25.49%	-53.62%	+4.18%	+115.98%	-23.52%	-24.05%	+1701.69%	+129.08%
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.00K	464.00K	291.00K	462.00K	550.00K	701.00K	1.01M	719.00K	640.00K	671.00K	686.00K	635.00K	6.19M	11.80M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	307.00K	326.00K	778.00K	1.28M	1.44M	2.01M	2.40M	861.00K	1.01M	2.88M	2.03M	1.43M	31.02M	73.43M
Gross Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	88.73%	41.27%	72.78%	73.55%	72.39%	74.18%	70.38%	54.49%	61.12%	81.13%	74.77%	69.25%	83.37%	86.16%
Operating Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	54.18M	33.34M	20.08M	16.50M	17.88M	20.18M	29.47M	20.77M	22.31M	27.41M	35.89M	39.61M	43.43M	72.77M
Operating Income	-2.12M	-600.00K	-1.03M	-2.07M	-1.90M	-2.31M	-3.37M	-3.11M	-11.70M	-6.91M	-8.07M	-13.54M	-30.74M	-46.46M	-53.87M	-33.02M	-19.30M	-15.21M	-16.44M	-18.16M	-27.07M	-19.91M	-21.30M	-24.53M	-33.85M	-38.18M	-12.41M	660.00K
Operating Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15569.65%	-4179.62%	-1805.80%	-870.64%	-825.30%	-669.06%	-794.57%	-1260.00%	-1294.23%	-690.04%	-1245.05%	-1849.01%	-33.36%	0.77%
EBITDA	-1.98M	-540.00K	-1.03M	-2.06M	-1.89M	-2.30M	-3.26M	-2.86M	-10.95M	-3.66M	-6.86M	-22.05M	-46.21M	-29.85M	-52.54M	-29.20M	-16.42M	-14.09M	-16.12M	-23.10M	-10.82M	-3.88M	-23.81M	-24.32M	-33.69M	-45.84M	-26.16M	3.86M
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15184.97%	-3695.95%	-1536.30%	-806.35%	-809.14%	-850.98%	-317.55%	-245.82%	-1446.78%	-684.02%	-1239.10%	-2219.85%	-70.31%	4.53%
Net Income	-2.05M	-570.00K	-960.18K	-1.88M	-1.81M	-2.25M	-3.27M	-2.86M	-10.95M	-3.66M	-6.86M	-22.06M	-46.68M	-30.89M	-51.87M	-30.32M	-17.38M	-14.70M	-17.97M	-45.12M	-19.22M	-8.88M	-24.16M	-25.65M	-36.51M	-47.68M	-26.39M	2.70M
Net Income Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14990.75%	-3838.48%	-1625.91%	-841.67%	-902.16%	-1661.77%	-564.19%	-561.96%	-1467.56%	-721.49%	-1342.70%	-2308.86%	-70.92%	3.17%
R&D	-	-	-	-	1.17M	1.60M	2.31M	1.74M	2.72M	4.24M	5.38M	9.64M	17.56M	25.17M	26.21M	12.69M	4.30M	6.49M	8.45M	10.49M	19.65M	9.49M	11.20M	13.78M	18.58M	17.50M	13.87M	29.25M
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7576.59%	1606.08%	402.15%	371.27%	424.10%	386.56%	576.75%	600.63%	680.50%	387.57%	683.45%	847.55%	37.29%	34.31%
Interest Expense	70.00K	30.00K	23.03K	15.57K	0	0	0	0	0	0	0	0	0	0	175.00K	81.00K	24.00K	67.00K	14.33M	21.70M	7.96M	4.75M	175.00K	1.19M	2.69M	1.44M	125.00K	-
Interest Expense % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50.58%	10.25%	2.25%	3.84%	719.28%	799.37%	233.61%	300.38%	10.63%	33.36%	98.75%	69.69%	0.34%	-

Balance Sheet

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	600.00K	5.93M	3.40M	1.81M	2.43M	7.35M	12.93M	8.76M	18.11M	11.36M	36.81M	50.58M	35.24M	30.47M	37.10M	23.76M	15.73M	35.24M	8.89M	6.84M	14.21M	34.63M	33.12M	17.86M	38.61M	76.59M	123.63M
Total Liabilities	-	110.00K	1.03M	176.08K	175.17K	260.20K	564.63K	330.07K	670.37K	1.68M	1.15M	13.05M	21.50M	9.14M	10.46M	7.00M	5.62M	7.13M	36.73M	8.21M	21.78M	20.57M	12.56M	21.17M	23.72M	22.84M	7.84M	12.41M
Total Equity	-	490.00K	4.91M	3.23M	1.64M	2.17M	6.79M	12.60M	8.09M	16.43M	10.21M	23.76M	29.08M	26.10M	20.01M	30.10M	18.14M	8.60M	-1.49M	678.00K	-14.94M	-6.36M	22.08M	11.95M	-5.86M	15.78M	68.75M	111.22M
Cash	-	560.00K	5.80M	3.30M	1.06M	313.62K	202.34K	1.70M	6.29M	7.89M	10.79M	35.49M	45.62M	25.78M	23.73M	31.25M	20.47M	12.61M	4.41M	4.00M	2.52M	10.00M	28.57M	22.80M	7.67M	12.65M	32.41M	43.45M
Total Debt	-	-	230.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13.34M	13.34M	2.04M	2.86M	2.94M	16.25M	15.87M	10.19M	1.04M	936.00K
Net Debt	-	-560.00K	-5.57M	-3.30M	-1.06M	-313.62K	-202.34K	-1.70M	-6.29M	-7.89M	-10.79M	-35.49M	-45.62M	-25.78M	-23.73M	-31.25M	-20.47M	-12.61M	8.93M	-4.00M	-478.00K	-7.14M	-25.63M	-6.55M	8.20M	-2.46M	-31.37M	-42.52M

Cash Flow

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.42M	-1.09M	-361.26K	-2.27M	-1.78M	-2.12M	-2.95M	-3.02M	-9.20M	-5.57M	-6.72M	-10.46M	-24.08M	-37.37M	-50.01M	-34.10M	-15.55M	-16.42M	-14.21M	-15.40M	-14.73M	-23.69M	-22.87M	-22.60M	-24.95M	-31.25M	-18.68M	22.52M
Investing Cash Flow	-	-	-	-13.26K	1.12M	-1.65M	-5.04M	-4.04M	8.69M	-7.49M	9.62M	3.53M	-3.13M	-6.09M	2.86M	-142.00K	-7.00K	10.00K	-1.34M	-524.00K	-76.00K	-24.00K	-782.00K	-143.00K	-209.00K	-19.71M	-981.00K	-26.59M
Financing Cash Flow	320.00K	800.00K	5.60M	-230.00K	-22.17K	3.02M	7.88M	8.56M	5.10M	14.65M	-	35.48M	37.35M	23.62M	45.06M	41.70M	4.87M	8.65M	7.41M	15.45M	13.24M	30.30M	42.35M	20.82M	10.14M	51.78M	39.41M	15.05M
Capital Expenditure	0	0	0	13.26K	6.66K	5.03K	5.35K	11.10M	5.42M	15.64K	8.31K	515.44K	1.64M	2.61M	2.12M	142.00K	44.00K	170.00K	258.00K	524.00K	76.00K	24.00K	782.00K	143.00K	209.00K	58.00K	559.00K	1.55M
Free Cash Flow	-1.42M	-1.09M	-361.26K	-2.28M	-1.79M	-2.13M	-2.95M	-14.12M	-14.63M	-5.58M	-6.73M	-10.98M	-25.72M	-39.98M	-52.13M	-34.24M	-15.60M	-16.59M	-14.47M	-15.92M	-14.81M	-23.71M	-23.65M	-22.75M	-25.16M	-31.31M	-19.24M	20.97M
Dividends Paid	-	-	499.54K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	527.00K	-	-	107.00K	-	-	51.78M	-	-
FCF to OCF	100.00%	100.00%	100.00%	100.59%	100.37%	100.24%	100.18%	467.57%	158.95%	100.28%	100.12%	104.93%	106.80%	106.98%	104.24%	100.42%	100.28%	101.04%	101.82%	103.40%	100.52%	100.10%	103.42%	100.63%	100.84%	100.19%	102.99%	93.13%
Dividend Paid to FCF	-	-	-138.28%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3.31%	-	-	-0.45%	-	-	-165.38%	-	-

Earnings

Report Date	Mar 31, 2002	Jun 30, 2002	Sep 30, 2002	Dec 31, 2002	Mar 31, 2003	Jun 30, 2003	Sep 30, 2003	Dec 31, 2003	Mar 31, 2004	Jun 30, 2004	Sep 30, 2004	Dec 31, 2004	Mar 31, 2005	Jun 30, 2005	Sep 30, 2005	Dec 31, 2005	Mar 31, 2006	Jun 30, 2006	Sep 30, 2006	Dec 31, 2006	May 10, 2007	Aug 9, 2007	Nov 28, 2007	Mar 12, 2008	May 9, 2008	Jul 25, 2008	Oct 24, 2008	Mar 11, 2009	Apr 17, 2009	Jul 27, 2009	Oct 23, 2009	Feb 26, 2010	May 5, 2010	Jul 29, 2010	Nov 2, 2010	Mar 8, 2011	May 5, 2011	Aug 4, 2011	Nov 7, 2011	Mar 8, 2012	May 8, 2012	Aug 7, 2012	Nov 7, 2012	Mar 13, 2013	May 8, 2013	Aug 6, 2013	Nov 6, 2013	Mar 12, 2014	May 7, 2014	Aug 6, 2014	Nov 5, 2014	Mar 10, 2015	May 6, 2015	Aug 5, 2015	Nov 10, 2015	Mar 18, 2016	May 4, 2016	Aug 15, 2016	Nov 10, 2016	Mar 29, 2017	May 9, 2017	Aug 8, 2017	Nov 14, 2017	Mar 16, 2018	May 10, 2018	Aug 14, 2018	Nov 13, 2018	Mar 13, 2019	Jun 14, 2019	Aug 8, 2019	Nov 14, 2019	Mar 25, 2020	May 14, 2020	Aug 13, 2020	Nov 11, 2020	Mar 31, 2021	May 11, 2021	Aug 10, 2021	Nov 9, 2021	Mar 25, 2022	May 10, 2022	Aug 8, 2022	Nov 8, 2022	Mar 27, 2023	May 22, 2023	Aug 9, 2023	Nov 13, 2023	Mar 26, 2024	May 14, 2024	Aug 5, 2024	Nov 8, 2024	Mar 6, 2025	May 12, 2025	Aug 6, 2025	Nov 4, 2025	Feb 26, 2026	May 7, 2026	Aug 6, 2026	Nov 3, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-	-	-	-	-	-0.19	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-108.07	-2.00	-2.11	-1.09	-1.03	-1.06	-1.13	-1.01	-0.86	-1.01	-1.04	-0.73	-0.62	-0.66	-0.49	-0.51	-0.45	-0.34	-0.19	0.01	0.03	0.03	-0.09	-0.06	-0.09	-0.16	-0.10
EPS Actual	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-0.57	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-1000000.00	-43922.48	-1347.43	-4493.76	-380.17	10.91	-7.26	-0.25	-0.17	-0.11	-0.08	-0.41	269.30	-108.07	-1.90	-1.16	-0.60	-1.04	-0.96	-0.94	-0.69	-1.00	-1.18	-0.92	-0.86	-0.77	-0.58	-1.14	-0.48	-0.45	-0.48	0.06	-0.11	0.03	0.07	0.02	-0.05	-0.03	0.07	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-	-	-	-526315689.42%	0.00%	0.00%	0.00%	0.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	5.00%	45.02%	44.95%	-0.97%	9.43%	16.81%	31.68%	-16.28%	-16.83%	11.54%	-17.81%	-24.19%	12.12%	-132.65%	5.88%	0.00%	-41.18%	131.58%	-1200.00%	15.38%	133.33%	122.22%	16.67%	66.67%	143.75%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	-	-	-	-	-	-	After-hours	After-hours	Pre-market	-	After-hours	Pre-market	After-hours	-	After-hours	Pre-market	After-hours	After-hours	-	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	Pre-market	After-hours	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap557.96M

Enterprise Value460.35M

Trailing P/E1608.00

Forward P/E232.56

PEG Ratio1.60

Price / Sales5.85

Price / Book4.70

EPS0.01

Book Value3.50

Revenue (TTM)95.42M

Gross Profit (TTM)83.06M

EBITDA-1.46M

Profit Margin0.56%

Operating Margin8.22%

Return on Equity0.47%

Return on Assets-0.89%

Shares Outstanding34.70M

Shares Float28.78M

Beta0.57

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 6 analystsTarget 24.00

Strong Buy
4
Buy
2

Ownership Breakdown

Institutions: 51.78%
Insiders: 8.09%
Retail / Other: 40.13%

Top Institutional Holders

Rosalind Advisors, Inc.
3.30M9.51%
BlackRock Inc
1.78M5.14%
Vanguard Capital Management, LLC
1.33M3.83%
Propel Bio Management LLC
871.46K2.51%
Geode Capital Management, LLC
692.03K1.99%
State Street Corp
664.43K1.91%
Algert Global LLC
580.71K1.67%
Millennium Management LLC
566.37K1.63%
Divisadero Street Capital Management, LP
499.80K1.44%
Ikarian Capital, LLC
431.25K1.24%
Morgan Stanley - Brokerage Accounts
385.52K1.11%
Private Wealth Advisors, LLC
310.86K0.90%
The Goldman Sachs Group Inc
289.13K0.83%
Simplify Asset Management Inc.
264.77K0.76%
Northern Trust Corp
251.86K0.73%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
889.41K2.56%
iShares Russell 2000 ETF
745.83K2.15%
Fidelity Small Cap Index
311.38K0.90%
Simplify Propel Opportunities ETF
241.97K0.70%
iShares Russell 2000 Value ETF
227.36K0.66%

Stock Splits

Dec 24, 20191:700